Screener
Discontinued — last reported Q1 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from Roivant Sciences’s reported figures.
Plus components not separately reported this period.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
FAQ
- What is Roivant Sciences's EBIT?
- Roivant Sciences (ROIV) reported EBIT of -$365.99M in Q2 2026.
- How has Roivant Sciences's EBIT changed year-over-year?
- Roivant Sciences's EBIT decreased by 28.5% year-over-year, from -$284.92M to -$365.99M.
- What is the long-term trend for Roivant Sciences's EBIT?
- Over 3 years (2021 to 2024), Roivant Sciences's EBIT has grown at a -9.5% compound annual growth rate (CAGR), from -$1.35B to -$1B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Roivant Sciences's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude